Overall Adminstration of Rare Diseases Clinical Research Consortia (RDCRC)
罕见病临床研究联盟(RDCRC)的总体管理
基本信息
- 批准号:8916167
- 负责人:
- 金额:$ 25.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:AwardBiometryBudgetsChildChild health careClinicalClinical ResearchClinical SciencesCollaborationsCommunicationCommunitiesDataData QualityDiseaseEffectivenessEnsureEvaluationFloridaFoundationsGoalsGuidelinesHealth Insurance Portability and Accountability ActHome environmentHuman DevelopmentIndustryInstitutesInternationalLeadershipMarshalMedical centerMedicineMinorityMonitorPatientsPersonsPilot ProjectsPoliciesPrincipal InvestigatorProceduresProductivityRare DiseasesRegulationResearchResearch DesignResourcesRoleSafetySiteStructureTraining ProgramsTraining and EducationTranslational ResearchUnited States National Institutes of HealthUniversitiesWomancollegedata managementhuman subject protectioninterestmeetingsoperationprogramssymposiumurea cycleweb site
项目摘要
The Urea Cycle Disorders Consortium's Administrative Unit coordinates all UCDC activities and is led by UCDC principal investigator/director, Mark L, Batshaw, MD. Co-principal investigators have spefic roles to ensure that the Consortium operates smoothly. Dr. Mendel Tuchman serves as Administrative Director and Co-PI, leading the the consortium when Dr, Batshaw is unable to do so, assisting Dr. Batshaw with Consortium administration and directing the clinical and pilot projects, Co-Pl Marshall Summar is responsible for industry and international relationships,assists Dr. Batshaw withUCDC administration and with Dr. Brendan Lee co-directs the training program: Co-Pl Cynthia LeMons is the executive director of the National Urea Cycle Disorders Foundation and serves as an advisor to the UCDC leadership, representing patients' interests in major UCDC decisions. She will also direct external communications from the UCDC to the patient community. Dr. Robert McCarter from Biostatistics and Study Design Unit at Children's Medical Center and Dr. Jeffrey Krischer from the Data Management and Coordinating Center at University of South Florida will advise the UCDC leadership on study design and results analysis. In addition to the directors. Dr. Brendan Lee at Baylor College of Medicine directs the training program, project manager Jennifer Seminara is responsible for UCDC operations, and Arlene Gendron assists with administrative duties. The UCDC holds monthly conference calls and one annual in-person meeting: The DMCCs audit program ensures quality data and is supplemented by a monitoring program directed by the UCDC project manager.
尿素循环障碍联盟的行政部门负责协调 UCDC 的所有活动,并由 UCDC 首席研究员/主任 Mark L, Batshaw, MD 领导。联合首席调查员具有特定的职责,以确保联盟顺利运作。 Mendel Tuchman 博士担任行政总监和联合首席研究员,当 Batshaw 博士无法领导该联盟时,协助 Batshaw 博士进行联盟管理并指导临床和试点项目,Co-Pl Marshall Summar 负责行业和国际关系,协助 Batshaw 博士处理 UCDC 行政事务,并与 Brendan Lee 博士共同指导培训计划:Co-Pl Cynthia LeMons 是国家中心的执行董事尿素循环障碍基金会并担任 UCDC 领导层的顾问,代表患者在 UCDC 重大决策中的利益。她还将指导 UCDC 与患者社区的外部沟通。儿童医学中心生物统计和研究设计部门的 Robert McCarter 博士和南佛罗里达大学数据管理和协调中心的 Jeffrey Krischer 博士将就研究设计和结果分析向 UCDC 领导层提供建议。除了董事之外。贝勒医学院的 Brendan Lee 博士指导培训计划,项目经理 Jennifer Seminara 负责 UCDC 运营,Arlene Gendron 协助行政工作。 UCDC 每月举行一次电话会议和一次年度面对面会议:DMCC 审核计划可确保数据质量,并由 UCDC 项目经理指导的监控计划作为补充。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mendel Tuchman其他文献
Mendel Tuchman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mendel Tuchman', 18)}}的其他基金
Pilot/Demonstration Clinical Research Projects Program
试点/示范临床研究项目计划
- 批准号:
8916164 - 财政年份:2015
- 资助金额:
$ 25.78万 - 项目类别:
N-acetylglutamate Synthase: Structure, Function & Defects
N-乙酰谷氨酸合成酶:结构、功能
- 批准号:
8035600 - 财政年份:2010
- 资助金额:
$ 25.78万 - 项目类别:
N-CARBAMYLGLUTAMATE (CARBAGLU) IN THE TREATMENT OF HYPERAMMONEMIA
N-氨甲酰谷氨酸(CARBAGLU)治疗高氨血症
- 批准号:
8167358 - 财政年份:2010
- 资助金额:
$ 25.78万 - 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
- 批准号:
8061384 - 财政年份:2010
- 资助金额:
$ 25.78万 - 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
- 批准号:
7848468 - 财政年份:2009
- 资助金额:
$ 25.78万 - 项目类别:
N-acetylglutamate Synthase: Structure, Function & Defects
N-乙酰谷氨酸合成酶:结构、功能
- 批准号:
7809804 - 财政年份:2009
- 资助金额:
$ 25.78万 - 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
- 批准号:
8254226 - 财政年份:2008
- 资助金额:
$ 25.78万 - 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
- 批准号:
8440307 - 财政年份:2008
- 资助金额:
$ 25.78万 - 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
- 批准号:
8613497 - 财政年份:2008
- 资助金额:
$ 25.78万 - 项目类别:
N-carbamylglutamate in the treatment of hyperammonemia
N-氨甲酰谷氨酸治疗高氨血症
- 批准号:
7667880 - 财政年份:2008
- 资助金额:
$ 25.78万 - 项目类别:
相似国自然基金
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
集成微流控芯片应用于高通量精准生物检体测定
- 批准号:
- 批准年份:2020
- 资助金额:60 万元
- 项目类别:面上项目
冬虫夏草抗菌肽的序列测定及其生物学功能研究
- 批准号:81803848
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
蔷薇科生命之树的建立及其在物种分布时空动态历史重建中的应用
- 批准号:31872679
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
诊断海洋病原微生物的多通道磁性“化学鼻”传感机制研究与验证
- 批准号:41866002
- 批准年份:2018
- 资助金额:40.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)
罗切斯特骨骼、肌肉和骨科研究资源中心 (ROCSTARR)(整体申请)
- 批准号:
10544989 - 财政年份:2022
- 资助金额:
$ 25.78万 - 项目类别:
NIA/AA for Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD Course)
NIA/AA ADRD 临床试验推进方法和方案研究所(NIA/AA IMPACT-AD 课程)
- 批准号:
10410305 - 财政年份:2022
- 资助金额:
$ 25.78万 - 项目类别:
NIA/AA for Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD Course)
NIA/AA ADRD 临床试验推进方法和方案研究所(NIA/AA IMPACT-AD 课程)
- 批准号:
10624324 - 财政年份:2022
- 资助金额:
$ 25.78万 - 项目类别: